Skip to content
TrialScanner

NCT03303066

Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)

Phase 2/Phase 3CompletedKYNBLeadAZNCollaborator

Registry record

Lead sponsor
Kyntra Bio
Conditions
Anemia; Myelodysplastic Syndrome
Primary completion
Jan 11, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03303066 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03303066: Efficacy and Safety of... | TrialScanner